Table 2.

Selected lncRNAs Involved in the Regulation of Glycolysis in Various Cancers

Cancer	lncRNAs	Expression in Cancer	Target	Model	Samples	References
Pancreatic ductal adenocarcinoma	PVT1	upregulation	HIF-1α	in vitro, in vivo, human		249
Hepatocellular carcinoma	SLC2A1-AS1	downregulation	STAT3/FOXM1/GLUT1 pathway	in vitro, in vivo, human	33	250
	LINC01554	downregulation	PKM2, Akt/mTOR signaling pathway	in vitro, in vivo, human	167	251
	HOTAIR	upregulation	HIF-1α	in vitro, human	38	252
Colorectal cancer	HNF1A-AS1	upregulation	MYO6	in vitro, human	40	253
	LINRIS	upregulation	IGF2BP2	in vitro, in vivo, human		254
	MAFG-AS1	upregulation	NDUFA4	in vitro, in vivo, human	52	255
	GLCC1	upregulation	LDHA	in vitro, in vivo, human	40	256
Non-small-cell lung cancer	BCYRN1	upregulation	PKM2	in vitro, human	20	257
	LINK-A	upregulation	HKII	in vitro, in vivo, human	113	258
	LINC00243	upregulation	PDK4	in vitro, human	70	259
	HOTTIP	upregulation	HMGB3	in vitro		260
Multiple myeloma	MALAT1	upregulation	SOX13	in vitro, in vivo, human	30	261
Endometrial carcinoma	SNHG16	upregulation	HK2	in vitro, in vivo, human		262
Glioma	LINC00174	upregulation	SLC2A1	in vitro, in vivo, human	45	239
	LINC00689	upregulation	PKM2	in vitro, in vivo, human	56	263
Esophageal cancer	LINC00184	upregulation	PTEN	in vitro, human	84	244
Cervical cancer	UCA1	upregulation	HK2	in vitro, human		264
Breast cancer	YIYA	upregulation	CDK6	in vitro, human		205
	MEG3	downregulation	PI3K/Akt pathway	in vitro, in vivo, human	20	265
Ovarian cancer, CAFs	LINC00092	upregulation	CXCL14	in vitro, in vivo, human	58	266
Nasopharyngeal carcinoma	ANRIL	upregulation	mTOR signaling pathway	in vitro, human	88	267
Lung cancer	IGFBP4-1	upregulation	HK2, PDK1, LDHA	in vitro, in vivo, human	159	268
Papillary thyroid carcinoma	ASMTL-AS1	downregulation	FOXO1	in vitro, in vivo, human	95	269
Ovarian cancer	LINC00504	upregulation	PKM2, HK2, PDK1	in vitro, human	45	270
Oral squamous cell carcinoma	p23154	upregulation	GLUT1	in vitro, in vivo, human	49	271
Pediatric acute myeloid leukemia	UCA1	upregulation	hexokinase 2 pathway	in vitro, human	31	272
Osteosarcoma	PVT1	upregulation	HK2	in vitro, human	46	273

CAF, cancer-associated fibroblast.